Smartphone app aims to combat malnutrition in head and neck cancer patients
NCT ID NCT06367257
First seen Jul 31, 2026 · Last updated Jul 31, 2026
Summary
This trial tests whether a smartphone app can help patients with head and neck cancer maintain their nutritional status during and after radiation therapy. Participants will use the app to regularly report their diet and well-being, with the goal of reducing weight loss and malnutrition. The study compares this app-based approach to standard supportive care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- App-based nutritional monitoring and optimization
- What this could lead to
- If effective, this approach could help head and neck cancer patients maintain better nutrition and reduce weight loss during and after treatment, potentially improving their overall health and recovery.
- What could go wrong
- The trial is relatively small and focuses on a specific patient group. The app's effectiveness may vary based on patient adherence and technological comfort, and it may not significantly improve outcomes compared to standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitätsklinikum Erlangen, Strahlenklinik
RECRUITINGErlangen, Bavaria, 91054, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can adding radiation boost immunotherapy against spread head and neck cancer?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- New hope for hard-to-treat cancers? experimental combo enters phase 2 trial
- New antibody drug aims to unleash immune system on Hard-to-Treat cancers
- Could fewer radiation sessions after surgery improve quality of life for head and neck cancer patients?
- New cocktail shows promise for tough head and neck cancer